 | Up a level |
2018
Martel, Samuel, Bruzzone, Marco 
ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Maurer, Christian, Ponde, Noam Falbel, Ferreira, Arlindo R., Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, Prady, Catherine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2018).
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat. Rev., 62.
S. 123 - 133.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1532-1967
Martel, Samuel, Lambertini, Matteo, Agbor-Tarh, Dominique, Ponde, Noam Falbel, Gombos, Andrea, Paterson, Vicki, Hilbers, Florentine ORCID: 0000-0002-6764-3102, Korde, Larissa, Manukyants, Anna, Dueck, Amylou C., Maurer, Christian, Piccart-Gebhart, Martine J., Moreno-Aspitia, Alvaro, Desmedt, Christine ORCID: 0000-0002-5223-5579, Di Cosimo, Serena and De Azambuja, Evandro
(2018).
Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial.
J. Clin. Oncol., 36 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755